Key Takeaways
- • Justin Ryan, former managing partner at Catalyst Investment Partners (late 1990s), now at Glow Capital Partners, has publicly disclosed controversial practices from his PE career through LinkedIn case studies, including requiring an HIV test of a CEO candidate.
- • The disclosure highlights governance and ethical gaps within private equity's historical operating practices, particularly regarding candidate screening procedures that would violate modern employment law and medical privacy standards.
- • Ryan's decision to publish retrospective case studies about Catalyst Investment Partners deals represents unusual transparency from a PE veteran, offering institutional investors rare insight into industry practices from that era.
- • The revelation underscores the opacity historically associated with private equity operations and the absence of rigorous regulatory oversight during the late 1990s compared to contemporary standards.
Summary
Justin Ryan, a private equity veteran and former managing partner at Catalyst Investment Partners, has disclosed that he required a CEO candidate to undergo an HIV test during the late 1990s. Ryan, now affiliated with Glow Capital Partners, has been publishing what he describes as "case studies" on LinkedIn documenting his experiences from his tenure at Catalyst Investment Partners, with this incident representing one of his recent disclosures.
The revelation is notable because it provides institutional investors with candid documentation of private equity industry practices from the late 1990s era—a period when deal scrutiny and regulatory frameworks differed substantially from contemporary standards. Such screening procedures would constitute violations of modern employment discrimination law and medical privacy regulations. Ryan's willingness to publicly detail these historical practices is atypical for PE professionals, who traditionally operate with significant opacity regarding deal execution and candidate evaluation methodologies.
The disclosure speaks to broader questions about governance standards and ethical practices within private equity during its earlier institutional development. While the late 1990s represented a different regulatory environment, the practice illustrates the discretionary power wielded by PE principals in transaction execution and the historical absence of standardized compliance protocols around candidate screening. For institutional investors evaluating PE fund managers, such disclosures provide valuable context regarding industry culture evolution and the importance of contemporary due diligence practices in assessing fund governance frameworks.
The revelation is notable because it provides institutional investors with candid documentation of private equity industry practices from the late 1990s era—a period when deal scrutiny and regulatory frameworks differed substantially from contemporary standards. Such screening procedures would constitute violations of modern employment discrimination law and medical privacy regulations. Ryan's willingness to publicly detail these historical practices is atypical for PE professionals, who traditionally operate with significant opacity regarding deal execution and candidate evaluation methodologies.
The disclosure speaks to broader questions about governance standards and ethical practices within private equity during its earlier institutional development. While the late 1990s represented a different regulatory environment, the practice illustrates the discretionary power wielded by PE principals in transaction execution and the historical absence of standardized compliance protocols around candidate screening. For institutional investors evaluating PE fund managers, such disclosures provide valuable context regarding industry culture evolution and the importance of contemporary due diligence practices in assessing fund governance frameworks.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.